BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 30045709)

  • 21. PTPRM, a candidate tumor suppressor gene in small intestinal neuroendocrine tumors.
    Barazeghi E; Hellman P; Westin G; Stålberg P
    Endocr Connect; 2019 Aug; 8(8):1126-1135. PubMed ID: 31349215
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early Expression of Tet1 and Tet2 in Mouse Zygotes Altered DNA Methylation Status and Affected Embryonic Development.
    Qi Q; Wang Q; Liu K; Bian J; Yu Z; Hou J
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955629
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Positive Effect of TET2 on the Osteogenic Differentiation of Human Adipose-Derived Mesenchymal Stem Cells.
    Feng L; Zhou J; Xia B; Tian BF
    Cell Reprogram; 2020 Feb; 22(1):3-13. PubMed ID: 31829736
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hydroxyurea promotes TET1 expression and induces apoptosis in osteosarcoma cells.
    Teng S; Ma C; Yu Y; Yi C
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 30988069
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Global hypomethylation and promoter methylation in small intestinal neuroendocrine tumors: an in vivo and in vitro study.
    Fotouhi O; Adel Fahmideh M; Kjellman M; Sulaiman L; Höög A; Zedenius J; Hashemi J; Larsson C
    Epigenetics; 2014 Jul; 9(7):987-97. PubMed ID: 24762809
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stage-specific roles for tet1 and tet2 in DNA demethylation in primordial germ cells.
    Vincent JJ; Huang Y; Chen PY; Feng S; Calvopiña JH; Nee K; Lee SA; Le T; Yoon AJ; Faull K; Fan G; Rao A; Jacobsen SE; Pellegrini M; Clark AT
    Cell Stem Cell; 2013 Apr; 12(4):470-8. PubMed ID: 23415914
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural insight into substrate preference for TET-mediated oxidation.
    Hu L; Lu J; Cheng J; Rao Q; Li Z; Hou H; Lou Z; Zhang L; Li W; Gong W; Liu M; Sun C; Yin X; Li J; Tan X; Wang P; Wang Y; Fang D; Cui Q; Yang P; He C; Jiang H; Luo C; Xu Y
    Nature; 2015 Nov; 527(7576):118-22. PubMed ID: 26524525
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Demethylation Status of Somatic DNA Extracted From Pituitary Neuroendocrine Tumors Indicates Proliferative Behavior.
    Szabó B; Németh K; Mészáros K; Szücs N; Czirják S; Reiniger L; Rajnai H; Krencz I; Karászi K; Krokker L; Patócs A; Butz H
    J Clin Endocrinol Metab; 2020 Jun; 105(6):. PubMed ID: 32232382
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dysregulation of DNA epigenetic modulators during prostate carcinogenesis in an eastern Indian patient population: Prognostic implications.
    Banerjee A; Bardhan A; Sarkar P; Datta C; Pal DK; Saha A; Ghosh A
    Pathol Res Pract; 2024 Jan; 253():154970. PubMed ID: 38056136
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Flanking sequences influence the activity of TET1 and TET2 methylcytosine dioxygenases and affect genomic 5hmC patterns.
    Adam S; Bräcker J; Klingel V; Osteresch B; Radde NE; Brockmeyer J; Bashtrykov P; Jeltsch A
    Commun Biol; 2022 Jan; 5(1):92. PubMed ID: 35075236
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alterations of regulatory factors and DNA methylation pattern in thyroid cancer.
    Iancu IV; Botezatu A; Plesa A; Huica I; Fudulu A; Albulescu A; Bostan M; Mihaila M; Grancea C; Manda DA; Dobrescu R; Vladoiu SV; Anton G; Badiu CV
    Cancer Biomark; 2020; 28(2):255-268. PubMed ID: 32390600
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tet1 and Tet2 regulate 5-hydroxymethylcytosine production and cell lineage specification in mouse embryonic stem cells.
    Koh KP; Yabuuchi A; Rao S; Huang Y; Cunniff K; Nardone J; Laiho A; Tahiliani M; Sommer CA; Mostoslavsky G; Lahesmaa R; Orkin SH; Rodig SJ; Daley GQ; Rao A
    Cell Stem Cell; 2011 Feb; 8(2):200-13. PubMed ID: 21295276
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methyl-CpG binding domain protein 1 regulates localization and activity of Tet1 in a CXXC3 domain-dependent manner.
    Zhang P; Rausch C; Hastert FD; Boneva B; Filatova A; Patil SJ; Nuber UA; Gao Y; Zhao X; Cardoso MC
    Nucleic Acids Res; 2017 Jul; 45(12):7118-7136. PubMed ID: 28449087
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduction of global 5-hydroxymethylcytosine is a poor prognostic factor in breast cancer patients, especially for an ER/PR-negative subtype.
    Tsai KW; Li GC; Chen CH; Yeh MH; Huang JS; Tseng HH; Fu TY; Liou HH; Pan HW; Huang SF; Chen CC; Chang HY; Ger LP; Chang HT
    Breast Cancer Res Treat; 2015 Aug; 153(1):219-34. PubMed ID: 26253945
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loss of 5-hydroxymethylcytosine in cancer: cause or consequence?
    Ficz G; Gribben JG
    Genomics; 2014 Nov; 104(5):352-7. PubMed ID: 25179374
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased 5-hydroxymethylcytosine and Ten-eleven Translocation Protein Expression in Ultraviolet B-irradiated HaCaT Cells.
    Wang D; Huang JH; Zeng QH; Gu C; Ding S; Lu JY; Chen J; Yang SB
    Chin Med J (Engl); 2017 Mar; 130(5):594-599. PubMed ID: 28229992
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2.
    Ko M; Huang Y; Jankowska AM; Pape UJ; Tahiliani M; Bandukwala HS; An J; Lamperti ED; Koh KP; Ganetzky R; Liu XS; Aravind L; Agarwal S; Maciejewski JP; Rao A
    Nature; 2010 Dec; 468(7325):839-43. PubMed ID: 21057493
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distinct roles of the methylcytosine oxidases Tet1 and Tet2 in mouse embryonic stem cells.
    Huang Y; Chavez L; Chang X; Wang X; Pastor WA; Kang J; Zepeda-Martínez JA; Pape UJ; Jacobsen SE; Peters B; Rao A
    Proc Natl Acad Sci U S A; 2014 Jan; 111(4):1361-6. PubMed ID: 24474761
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hydrogen Sulfide Promotes Tet1- and Tet2-Mediated Foxp3 Demethylation to Drive Regulatory T Cell Differentiation and Maintain Immune Homeostasis.
    Yang R; Qu C; Zhou Y; Konkel JE; Shi S; Liu Y; Chen C; Liu S; Liu D; Chen Y; Zandi E; Chen W; Zhou Y; Shi S
    Immunity; 2015 Aug; 43(2):251-63. PubMed ID: 26275994
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in DNA 5-Hydroxymethylcytosine Levels and the Underlying Mechanism in Non-functioning Pituitary Adenomas.
    Xu Y; Niu Y; Deng K; Pan H; Feng F; Gong F; Tong WM; Chen S; Lu L; Wang R; You H; Yao Y; Zhu H
    Front Endocrinol (Lausanne); 2020; 11():361. PubMed ID: 32774324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.